GEHC · PEAD ↑ 45

GE HealthCare reported Q2 2026 EPS of $1.13 on 2026-07-29, beating the $1.04 consensus by $0.09 (+8.7%).

Print-day reaction was +12.2% versus the prior close, a sharp gap-and-continue move driven by the EPS beat. The overnight gap to the T+1 open was a modest -0.7%, signalling a slight fade but no material reversal after-hours. Over the following two trading days, price drifted -0.3% from the T+1 close through the T+3 close, essentially consolidating the initial surge rather than extending it. Cumulative abnormal return of +6.5% versus SPY.US places this firmly in PEAD long territory; per the documented pattern, the read is held through 2026-10-26.